US Patent 9371553 Genetically modified mice that produce hybrid antibodies
Patent 9371553 was granted and assigned to Regeneron Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 4, 2013
0
Date of Patent
June 21, 2016
0
Patent Applicant
Patent Application Number
14046279
0
Patent Inventor Names
Sean Stevens
0
Andrew J. Murphy
0
Aris N. Economides
0
David M. Valenzuela
0
George D. Yancopoulos
0
Lynn Macdonald
0
Margaret Karow
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9371553 Genetically modified mice that produce hybrid antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
